OCRHIPAA Privacy Rule

HIPAA De-Identification Standard (45 CFR 164.514(a)-(b))

Two methods for de-identifying PHI so that it is no longer subject to the Privacy Rule: the Safe Harbor method removing 18 identifier categories, and the Expert Determination method.

Primary source

45 CFR 164.514(a)-(b) — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-E/section-164.514

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

45 CFR 164.514(a)-(b) provides two methods to de-identify PHI; once de-identified, the data is no longer PHI and the Privacy Rule does not restrict its use or disclosure.

Safe Harbor (164.514(b)(2)): remove 18 categories of identifiers — name, geographic subdivisions smaller than a state (with limited 3-digit ZIP carve-outs for ZIPs over 20,000 population), all elements of dates except year for dates directly related to the individual, telephone, fax, email, SSN, MRN, plan beneficiary number, account number, certificate/license number, vehicle identifier, device identifier, URL, IP address, biometric identifier, full-face photograph, and any other unique identifier. The covered entity must also have no actual knowledge that the residual data could re-identify the individual.

Expert Determination (164.514(b)(1)): a qualified statistician or domain expert documents a determination that the risk of re-identification is very small and the methods used to support that determination.

OCR's de-identification guidance walks small practices through both methods. Limited data sets per 164.514(e) sit between de-identified and full PHI and are still subject to HIPAA via a data use agreement.

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.